• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

pediatric

red blood cells
Biotech

Novo adds pediatric data to bulging bag of hemophilia A evidence

Novo has bolstered the case for its near-approval candidate, linking the prospect to reductions in treated bleeds in children with hemophilia A.
Nick Paul Taylor Feb 7, 2025 5:28am
FDA

FDA opens use of J&J's Impella heart pumps to pediatric patients

Dec 12, 2024 2:30pm
JNJ

J&J posts adolescent myasthenia gravis data on $6B FcRn blocker

Oct 15, 2024 9:25am
tandem bike kid toddler

FDA OKs Tandem’s automated insulin algorithm for toddlers

Nov 8, 2023 10:16am
Etiometry IVCO2 index

FDA expands OK for Etiometry's NICU AI

Aug 2, 2023 3:40pm
Graphic of a number of arrows missing the bullseye on a target except for one arrow

Applied fails phase 3 trial, plans to seek approval anyway

Apr 24, 2023 9:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings